Kapiva, a pioneer in modern Ayurvedic healthcare, landed over $60 million in a Series D funding round.WHO: Kapiva was founded in 2016 by Ameve Sharma and Shrey Badhani. Sharma is a third-generation entrepreneur from the Baidyanath Group, a traditional Indian Ayurvedic company. Kapiva is a modern Ayurvedic brand that has successfully integrated Ayurveda into the daily lives of consumers by offering simple, accessible, and effective wellness solutions. It provides authentic products using research, science-backed Ayurveda, and the finest ingredients. The brand recently expanded globally, including the Middle East, Europe, and North America, with a wholly owned US subsidiary, Kapiva Inc., and is present across 40,000 stores in India.WHY: The fresh capital will be deployed to strengthen Kapiva’s research and development, manufacturing capabilities, invest in brand building at scale, and build a strong health-tech ecosystem.IN THEIR OWN WORDS: "We set out to build consumer trust with evidence, and not just claims," said Ameve Sharma, founder of Kapiva. "This funding represents confidence in our vision to make Ayurveda the preferred choice for holistic wellness. Our strong results from clinical trials on our Blood Sugar supplement Dia Free Juice and our Sports Nutrition supplement Shilajit Gold, reflects our commitment to products that are both accessible and proven. We are making our products accessible to consumers across channels from our own website to ecommerce and now a fast growing offline channel with a reach of about 40,000 stores.